{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:29:37Z","timestamp":1787315377710,"version":"build-2736575974"},"reference-count":251,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2019.01172","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T23:26:07Z","timestamp":1573169167000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":91,"title":["Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria Grazia","family":"Rossino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dal Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Casini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/nyas.12412","article-title":"Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment","volume":"1311","author":"Abcouwer","year":"2014","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3181\/0902-MR-78","article-title":"Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis","volume":"234","author":"Aggarwal","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00125-010-1994-3","article-title":"Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected]","volume":"54","author":"Al-Gayyar","year":"2011","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2018.06.025","article-title":"Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats","volume":"176","author":"Alrashdi","year":"2018","journal-title":"Exp. Eye Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1167\/iovs.16-19285","article-title":"VEGF as a survival factor in ex vivo models of early diabetic retinopathy","volume":"57","author":"Amato","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.phrs.2017.09.022","article-title":"Autophagy-mediated neuroprotection induced by octreotide in an ex vivo model of early diabetic retinopathy","volume":"128","author":"Amato","year":"","journal-title":"Pharmacol. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"E1932","DOI":"10.3390\/nu10121932","article-title":"Lisosan G protects the retina from neurovascular damage in experimental diabetic retinopathy","volume":"10","author":"Amato","year":"","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fncel.2014.00333","article-title":"Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress","volume":"8","author":"Arredondo Zamarripa","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1749-6632.2010.05512.x","article-title":"Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects","volume":"1200","author":"Atlasz","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12031-018-1229-5","article-title":"Retinoprotective effects of TAT-bound vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide","volume":"68","author":"Atlasz","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature02544","article-title":"VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model","volume":"429","author":"Azzouz","year":"2004","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.14670\/HH-18.1219","article-title":"Expression of neuropeptides and their receptors in the developing retina of mammals","volume":"18","author":"Bagnoli","year":"2003","journal-title":"Histol. Histopathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0278-5846(03)00023-X","article-title":"A new view of diabetic retinopathy: a neurodegenerative disease of the eye","volume":"27","author":"Barber","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","article-title":"Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide","volume":"72","author":"Bassan","year":"1999","journal-title":"J. Neurochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e100954","DOI":"10.1371\/journal.pone.0100954","article-title":"Combined renin inhibition\/(pro)renin receptor blockade in diabetic retinopathy\u2013a study in transgenic (mREN2)27 rats","volume":"9","author":"Batenburg","year":"2014","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ajpath.2013.05.031","article-title":"VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro","volume":"183","author":"Beazley-Long","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1742-1241.1999.tb11820.x","article-title":"Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy","volume":"53","author":"Berthet","year":"1999","journal-title":"Int. J. Clin. Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E3578","DOI":"10.3390\/ijms19113578","article-title":"Topical administration of bosentan prevents retinal neurodegeneration in experimental diabetes","volume":"19","author":"Bogdanov","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.jdiacomp.2017.07.009","article-title":"Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db\/db mice","volume":"31","author":"Bogdanov","year":"2017","journal-title":"J. Diabetes Complications"},{"key":"B21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nbt0898-728","article-title":"Nutraceuticals: poised for a healthy slice of the healthcare market?","volume":"16","author":"Brower","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-2999(98)00604-9","article-title":"Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat","volume":"358","author":"Brunet","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bcp.2012.03.019","article-title":"Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats","volume":"84","author":"Bucolo","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1159\/000487029","article-title":"Alpha-melanocyte-stimulating hormone protects early diabetic retina from blood-retinal barrier breakdown and vascular leakage via MC4R","volume":"45","author":"Cai","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.7150\/ijms.20962","article-title":"GLP-1 treatment improves diabetic retinopathy by alleviating autophagy through GLP-1R-ERK1\/2-HDAC6 signaling pathway","volume":"14","author":"Cai","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2904150","DOI":"10.1155\/2017\/2904150","article-title":"Diabetic retinopathy in the spontaneously diabetic torii rat: pathogenetic mechanisms and preventive efficacy of inhibiting the urokinase-type plasminogen activator receptor system","volume":"2017","author":"Cammalleri","year":"","journal-title":"J. Diabetes Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1111\/jcmm.14391","article-title":"The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: new pre-clinical evidence in the rd10 mouse model","volume":"23","author":"Cammalleri","year":"","journal-title":"J. Cell Mol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"E925","DOI":"10.3390\/cells8080925","article-title":"The uPAR system as a potential therapeutic target in the diseased eye","volume":"8","author":"Cammalleri","year":"","journal-title":"Cells"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1167\/iovs.17-21593","article-title":"The urokinase receptor-derived peptide UPARANT recovers dysfunctional electroretinogram and blood-retinal barrier leakage in a rat model of diabetes","volume":"58","author":"Cammalleri","year":"","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.14670\/HH-20.615","article-title":"Functional aspects of the somatostatinergic system in the retina and the potential therapeutic role of somatostatin in retinal disease","volume":"20","author":"Casini","year":"2005","journal-title":"Histol. Histopathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.preteyeres.2014.06.001","article-title":"The beta-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases","volume":"42","author":"Casini","year":"2014","journal-title":"Prog. Retin Eye Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/j.1460-9568.2007.05419.x","article-title":"Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression","volume":"25","author":"Catalani","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5856071","DOI":"10.1155\/2017\/5856071","article-title":"Current evidence for a role of neuropeptides in the regulation of autophagy","volume":"2017","author":"Catalani","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2013.09.003","article-title":"Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1","volume":"18","author":"Cerani","year":"2013","journal-title":"Cell Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3109\/02713683.2010.483312","article-title":"Pharmacological inhibition of N-methyl d-aspartate receptor promotes secretion of vascular endothelial growth factor in muller cells: effects of hyperglycemia and hypoxia","volume":"35","author":"Cervantes-Villagrana","year":"2010","journal-title":"Curr. Eye Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1570159X11311010011","article-title":"The Neuropeptide systems and their potential role in the treatment of mammalian retinal ischemia: a developing story","volume":"11","author":"Cervia","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mce.2007.12.009","article-title":"Physiology and pathology of somatostatin in the mammalian retina: a current view","volume":"286","author":"Cervia","year":"","journal-title":"Mol. Cell Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.3390\/jcm8081146","article-title":"Neuroprotective peptides in retinal disease","volume":"8","author":"Cervia","year":"2019","journal-title":"J. Clin. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1471-4159.2011.07622.x","article-title":"Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin","volume":"120","author":"Cervia","year":"2012","journal-title":"J. Neurochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/j.1471-4159.2008.05556.x","article-title":"Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas","volume":"106","author":"Cervia","year":"","journal-title":"J. Neurochem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e55291","DOI":"10.1371\/journal.pone.0055291","article-title":"Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-alpha-induced damage","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS ONE"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/2231-4040.107494","article-title":"Current concepts and prospects of herbal nutraceutical: a review","volume":"4","author":"Chauhan","year":"2013","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3892\/etm.2017.5275","article-title":"Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy","volume":"14","author":"Chen","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3389\/fphys.2017.01065","article-title":"Tang Wang Ming Mu granule attenuates diabetic retinopathy in type 2 diabetes rats","volume":"8","author":"Chen","year":"2017","journal-title":"Front. Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3389\/fnmol.2018.00493","article-title":"Neuropeptides exert neuroprotective effects in Alzheimer's disease","volume":"11","author":"Chen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2337\/db11-0413","article-title":"Therapeutic effects of PPARalpha agonists on diabetic retinopathy in type 1 diabetes models","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.exer.2018.11.023","article-title":"Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1","volume":"181","author":"Chen","year":"2019","journal-title":"Exp. Eye Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1167\/iovs.13-13676","article-title":"Endothelin receptor-A antagonist attenuates retinal vascular and neuroretinal pathology in diabetic mice","volume":"55","author":"Chou","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5615647","DOI":"10.1155\/2017\/5615647","article-title":"Green tea extracts epigallocatechin-3-gallate for different treatments","volume":"2017","author":"Chu","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1002\/jnr.22046","article-title":"Neuroprotective role of erythropoietin by antiapoptosis in the retina","volume":"87","author":"Chung","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/hmg\/ddr115","article-title":"Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration","volume":"20","author":"Colella","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00210-012-0735-1","article-title":"Protective role of somatostatin receptor 2 against retinal degeneration in response to hypoxia","volume":"385","author":"Dal Monte","year":"2012","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00210-002-0662-7","article-title":"Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina","volume":"367","author":"Dal Monte","year":"2003","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1167\/iovs.09-3412","article-title":"Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2","volume":"50","author":"Dal Monte","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1167\/iovs.09-4472","article-title":"Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy","volume":"51","author":"Dal Monte","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1039\/c3mb70362b","article-title":"Protective effects of the neuropeptides PACAP, substance P and the somatostatin analogue octreotide in retinal ischemia: a metabolomic analysis","volume":"10","author":"D'alessandro","year":"2014","journal-title":"Mol. Biosyst."},{"key":"B59","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12031-016-0869-6","article-title":"Nap interferes with hypoxia-inducible factors and VEGF expression in retina of diabetic rats","volume":"61","author":"D'amico","year":"","journal-title":"J. Mol. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1002\/jcp.27331","article-title":"NAP modulates hyperglycemic-inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage","volume":"234","author":"D'amico","year":"2019","journal-title":"J. Cell Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.peptides.2017.09.014","article-title":"Modulation of IL-1beta and VEGF expression in rat diabetic retinopathy after PACAP administration","volume":"97","author":"D'amico","year":"","journal-title":"Peptides"},{"key":"B62","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s12031-015-0621-7","article-title":"PACAP modulates expression of hypoxia-inducible factors in streptozotocin-induced diabetic rat retina","volume":"57","author":"D'amico","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12031-014-0296-5","article-title":"PACAP application improves functional outcome of chronic retinal ischemic injury in rats-evidence from electroretinographic measurements","volume":"54","author":"Danyadi","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1172\/JCI76492","article-title":"Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk","volume":"124","author":"Dejda","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B66","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1167\/iovs.17-22920","article-title":"Nrf2 activation is a potential therapeutic approach to attenuate diabetic retinopathy","volume":"59","author":"Deliyanti","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1167\/iovs.16-21402","article-title":"Therapeutic effects of a novel agonist of peroxisome proliferator-activated receptor alpha for the treatment of diabetic retinopathy","volume":"58","author":"Deng","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuro.2018.06.005","article-title":"Aldehyde dehydrogenase 2 in the spotlight: the link between mitochondria and neurodegeneration","volume":"68","author":"Deza-Ponzio","year":"2018","journal-title":"Neurotoxicology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/CS20150093","article-title":"Are reactive oxygen species still the basis for diabetic complications?","volume":"129","author":"Di Marco","year":"2015","journal-title":"Clin. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0167853","DOI":"10.1371\/journal.pone.0167853","article-title":"The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy","volume":"11","author":"Dietrich","year":"2016","journal-title":"PLoS ONE"},{"key":"B71","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejphar.2018.06.011","article-title":"Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin\/nicotinamide induced pre-diabetes","volume":"833","author":"Djordjevic","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1610751","DOI":"10.1155\/2018\/1610751","article-title":"Protection of kaempferol on oxidative stress-induced retinal pigment epithelial cell damage","volume":"2018","author":"Du","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"B74","doi-asserted-by":"publisher","first-page":"93751","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.04.015","article-title":"Immunosuppressive activity of a novel peptide analog of alpha-melanocyte stimulating hormone (alpha-MSH) in experimental autoimmune uveitis","volume":"236","author":"Edling","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.exer.2014.05.004","article-title":"Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats","volume":"127","author":"Fan","year":"","journal-title":"Exp. Eye Res."},{"key":"B77","first-page":"1557","article-title":"Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2\/Bax and Bcl-xL\/Bax ratios and reducing reactive gliosis","volume":"20","author":"Fan","year":"","journal-title":"Mol. Vis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.preteyeres.2010.03.003","article-title":"The renin-angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature","volume":"29","author":"Fletcher","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/eye.2012.161","article-title":"Vitreous levels of somatostatin in patients with chronic uveitic macular oedema","volume":"26","author":"Fonollosa","year":"2012","journal-title":"Eye"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1590\/1414-431x20154583","article-title":"Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina","volume":"48","author":"Foureaux","year":"2015","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1167\/iovs.12-11427","article-title":"Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2","volume":"54","author":"Foureaux","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.ajpath.2012.12.032","article-title":"VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma","volume":"182","author":"Foxton","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10571-007-9155-z","article-title":"Up-regulated endogenous erythropoietin\/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension","volume":"28","author":"Fu","year":"2008","journal-title":"Cell Mol. Neurobiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1167\/iovs.11-9167","article-title":"Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels","volume":"53","author":"Fujita","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/bcp.12003","article-title":"Neuropeptides and diabetic retinopathy","volume":"75","author":"Gabriel","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1172\/JCI34508","article-title":"Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation","volume":"118","author":"Garcia","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2478\/acb-2014-0006","article-title":"Antioxidant properties of resveratrol and its protective effects in neurodegenerative diseases","volume":"4","author":"Gerszon","year":"2014","journal-title":"Med. J. Cell Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12031-007-9003-0","article-title":"Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo","volume":"33","author":"Giladi","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1442-9071.2009.02108.x","article-title":"Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy","volume":"37","author":"Goldenberg-Cohen","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/j.1463-1326.2011.01548.x","article-title":"Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model","volume":"14","author":"Goncalves","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1167\/iovs.15-19006","article-title":"Protective effect of a GLP-1 analog on ischemia-reperfusion induced blood-retinal barrier breakdown and inflammation","volume":"57","author":"Goncalves","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbadis.2014.04.013","article-title":"Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats","volume":"9","author":"Goncalves","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neulet.2015.02.059","article-title":"Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis","volume":"592","author":"Guo","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B94","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/jop.2010.0123","article-title":"Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms","volume":"27","author":"Gupta","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"B95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00125-017-4435-8","article-title":"Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond","volume":"61","author":"Hammes","year":"2018","journal-title":"Diabetologia"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/en.2003-1058","article-title":"Distribution of the VPAC2 receptor in peripheral tissues of the mouse","volume":"145","author":"Harmar","year":"2004","journal-title":"Endocrinology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.lfs.2018.10.019","article-title":"ALDH2 attenuates early-stage STZ-induced aged diabetic rats retinas damage via Sirt1\/Nrf2 pathway","volume":"215","author":"He","year":"2018","journal-title":"Life Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1111\/dom.13339","article-title":"Glucagon-like peptide-1 receptor expression in the human eye","volume":"20","author":"Hebsgaard","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"B99","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes","volume":"65","author":"Hernandez","year":"","journal-title":"Diabetes"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00125-017-4388-y","article-title":"Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes","volume":"60","author":"Hernandez","year":"2017","journal-title":"Diabetologia"},{"key":"B101","doi-asserted-by":"publisher","first-page":"9508541","DOI":"10.1155\/2016\/9508541","article-title":"Neuroprotection as a therapeutic target for diabetic retinopathy","volume":"2016","author":"Hernandez","year":"","journal-title":"J. Diabetes Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2337\/dc06-0556","article-title":"Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema","volume":"29","author":"Hernandez","year":"2006","journal-title":"Diabetes Care"},{"key":"B103","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2337\/db12-0926","article-title":"Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes","volume":"62","author":"Hernandez","year":"2013","journal-title":"Diabetes"},{"key":"B104","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11892-012-0284-5","article-title":"Neuroprotection in diabetic retinopathy","volume":"12","author":"Hernandez","year":"2012","journal-title":"Curr. Diab. Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12020-014-0232-z","article-title":"Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives","volume":"46","author":"Hernandez","year":"2014","journal-title":"Endocrine"},{"key":"B106","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"E92","DOI":"10.3390\/foods6100092","article-title":"Curcumin: a review of its' effects on human health","volume":"6","author":"Hewlings","year":"2017","journal-title":"Foods"},{"key":"B108","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S1474-4422(03)00482-4","article-title":"Neuropeptides: opportunities for drug discovery","volume":"2","author":"Hokfelt","year":"2003","journal-title":"Lancet Neurol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"18316","DOI":"10.1038\/srep18316","article-title":"Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse","volume":"5","author":"Hombrebueno","year":"2015","journal-title":"Sci. Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1463-5224.2012.01018.x","article-title":"The protective effects of Lycium barbarum and Chrysanthemum morifolum on diabetic retinopathies in rats","volume":"2","author":"Hu","year":"2012","journal-title":"Vet. Ophthalmol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"15401","DOI":"10.1073\/pnas.1307211110","article-title":"Pathogenic role of diabetes-induced PPAR-alpha down-regulation in microvascular dysfunction","volume":"110","author":"Hu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/nn.2953","article-title":"Stroke research at a crossroad: asking the brain for directions","volume":"14","author":"Iadecola","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000356193","article-title":"Physiology and pharmacology of erythropoietin","volume":"40","author":"Jelkmann","year":"2013","journal-title":"Transfus Med. Hemother."},{"key":"B114","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.3390\/molecules22040610","article-title":"The pharmacological effects of lutein and zeaxanthin on visual disorders and cognition diseases","volume":"22","author":"Jia","year":"2017","journal-title":"Molecules"},{"key":"B115","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s12035-014-8732-7","article-title":"Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy","volume":"51","author":"Jindal","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"E1046","DOI":"10.3390\/nu10081046","article-title":"Chrysin ameliorates malfunction of retinoid visual cycle through blocking activation of AGE-RAGE-ER stress in glucose-stimulated retinal pigment epithelial cells and diabetic eyes","volume":"10","author":"Kang","year":"2018","journal-title":"Nutrients"},{"key":"B117","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/nu8120782","article-title":"Dietary compound chrysin inhibits retinal neovascularization with abnormal capillaries in db\/db mice","volume":"8","author":"Kang","year":"2016","journal-title":"Nutrients"},{"key":"B118","doi-asserted-by":"publisher","first-page":"797824","DOI":"10.1155\/2014\/797824","article-title":"Protective effect of hesperetin and naringenin against apoptosis in ischemia\/reperfusion-induced retinal injury in rats","volume":"30","author":"Kara","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"key":"B120","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuropharm.2009.06.028","article-title":"Activation of somatostatin receptor (sst 5) protects the rat retina from AMPA-induced neurotoxicity","volume":"58","author":"Kiagiadaki","year":"2010","journal-title":"Neuropharmacology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1167\/iovs.07-1644","article-title":"Effect of intravitreal administration of somatostatin and sst2 analogs on AMPA-induced neurotoxicity in rat retina","volume":"49","author":"Kiagiadaki","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1096\/fj.04-2493fje","article-title":"Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1\/-2","volume":"19","author":"Kilic","year":"2005","journal-title":"FASEB J."},{"key":"B123","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3109\/09637486.2014.979319","article-title":"Vaccinium myrtillus extract prevents or delays the onset of diabetes\u2013induced blood-retinal barrier breakdown","volume":"66","author":"Kim","year":"2015","journal-title":"Int. J. Food Sci. Nutr."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2337\/db09-1431","article-title":"Resveratrol inhibits neuronal apoptosis and elevated Ca2+\/calmodulin-dependent protein kinase II activity in diabetic mouse retina","volume":"59","author":"Kim","year":"2010","journal-title":"Diabetes"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1755-3768.2011.02243.x","article-title":"Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas","volume":"90","author":"Kim","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.exer.2012.08.005","article-title":"Pasireotide (SOM230) protects the retina in animal models of ischemia induced retinopathies","volume":"103","author":"Kokona","year":"2012","journal-title":"Exp. Eye Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1186\/1743-7075-4-8","article-title":"Effects of curcumin on retinal oxidative stress and inflammation in diabetes","volume":"4","author":"Kowluru","year":"2007","journal-title":"Nutr. Metab."},{"key":"B128","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.preteyeres.2015.05.001","article-title":"Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy","volume":"48","author":"Kowluru","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1167\/iovs.07-0764","article-title":"Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats","volume":"49","author":"Kowluru","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1186\/1743-7075-11-8","article-title":"Beneficial effects of the nutritional supplements on the development of diabetic retinopathy","volume":"11","author":"Kowluru","year":"2014","journal-title":"Nutr. Metab."},{"key":"B131","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1167\/iovs.08-2666","article-title":"Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation","volume":"50","author":"Kubota","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"9142","DOI":"10.1167\/iovs.11-8041","article-title":"Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation","volume":"52","author":"Kubota","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000330051","article-title":"Green tea prevents hyperglycemia-induced retinal oxidative stress and inflammation in streptozotocin-induced diabetic rats","volume":"47","author":"Kumar","year":"","journal-title":"Ophthalmic Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.exer.2014.06.009","article-title":"Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats","volume":"125","author":"Kumar","year":"2014","journal-title":"Exp. Eye Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.vph.2012.02.007","article-title":"Hesperetin ameliorates hyperglycemia induced retinal vasculopathy via anti-angiogenic effects in experimental diabetic rats","volume":"57","author":"Kumar","year":"","journal-title":"Vascul. Pharmacol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mvr.2013.01.002","article-title":"Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats","volume":"87","author":"Kumar","year":"2013","journal-title":"Microvasc. Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1167\/iovs.08-3293","article-title":"Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine","volume":"51","author":"Kusari","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s11064-015-1607-0","article-title":"Pituitary adenylate cyclase-activating polypeptide receptors signal via phospholipase c pathway to block apoptosis in newborn rat retina","volume":"40","author":"Lakk","year":"2015","journal-title":"Neurochem. Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2337\/db09-1421","article-title":"Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes","volume":"59","author":"Leal","year":"2010","journal-title":"Diabetes"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2337\/dc15-2171","article-title":"Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010","volume":"39","author":"Leasher","year":"2016","journal-title":"Diabetes Care"},{"key":"B141","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.3390\/molecules190812150","article-title":"Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation","volume":"19","author":"Lee","year":"2014","journal-title":"Molecules"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1080\/02713683.2018.1501072","article-title":"Fenofibrate ameliorates oxidative stress-induced retinal microvascular dysfunction in diabetic rats","volume":"43","author":"Li","year":"2018","journal-title":"Curr. Eye Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"F469","DOI":"10.1152\/ajprenal.00038.2005","article-title":"Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF","volume":"289","author":"Li","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"392","DOI":"10.14336\/AD.2016.1227","article-title":"Limb remote ischemic conditioning promotes myelination by upregulating PTEN\/Akt\/mTOR signaling activities after chronic cerebral hypoperfusion","volume":"8","author":"Li","year":"2017","journal-title":"Aging Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3969\/j.issn.1000-4432.2011.02.017","article-title":"Intravitreous high expression level of netrin-1 in patients with proliferative diabetic retinopathy","volume":"26","author":"Liu","year":"2011","journal-title":"Eye Sci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-017-3256-x","article-title":"Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation","volume":"445","author":"Liu","year":"2018","journal-title":"Mol Cell Biochem."},{"key":"B147","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00441-018-2974-z","article-title":"Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt\/beta-catenin pathway activation","volume":"376","author":"Liu","year":"2019","journal-title":"Cell Tissue Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00417-015-2969-3","article-title":"Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats","volume":"253","author":"Liu","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.exer.2011.12.012","article-title":"Activation of the aldosterone\/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury","volume":"96","author":"Liu","year":"2012","journal-title":"Exp. Eye Res."},{"key":"B150","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.2174\/0929867321666140217124945","article-title":"Davunetide: peptide therapeutic in neurological disorders","volume":"21","author":"Magen","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00394-016-1214-0","article-title":"Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism","volume":"56","author":"Mahmoud","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s10792-017-0768-z","article-title":"Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells","volume":"38","author":"Marangoz","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/02713680500478923","article-title":"An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina","volume":"31","author":"Masuzawa","year":"2006","journal-title":"Curr. Eye Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/path.3006","article-title":"Mechanisms underlying somatostatin receptor 2 down-regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants","volume":"226","author":"Mei","year":"2012","journal-title":"J. Pathol."},{"key":"B155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/B978-0-12-802147-7.00029-2","article-title":"Oxidative stress and excitotoxicity: antioxidants from nutraceuticals","volume-title":"Nutraceuticals","author":"Milatovic","year":"2016"},{"key":"B156","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1167\/iovs.16-19759","article-title":"The role of DNA methylation in the metabolic memory phenomenon associated with the continued progression of diabetic retinopathy","volume":"57","author":"Mishra","year":"2016","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"B157","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12035-018-1086-9","article-title":"DNA methylation-a potential source of mitochondria DNA base mismatch in the development of diabetic retinopathy","volume":"56","author":"Mishra","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"H738","DOI":"10.1152\/ajpheart.00005.2016","article-title":"Neurovascular cross talk in diabetic retinopathy: pathophysiological roles and therapeutic implications","volume":"311","author":"Moran","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.bbrc.2007.07.059","article-title":"Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina","volume":"361","author":"Mrudula","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B160","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fendo.2012.00145","article-title":"Distribution and protective function of pituitary adenylate cyclase-activating polypeptide in the retina","volume":"3","author":"Nakamachi","year":"2012","journal-title":"Front. Endocrinol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2014.03.020","article-title":"Angiotensin II type 1 receptor blockade suppresses light-induced neural damage in the mouse retina","volume":"71","author":"Narimatsu","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"B162","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1096\/fj.08-110155","article-title":"A peptide inhibitor of the urokinase\/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes","volume":"22","author":"Navaratna","year":"2008","journal-title":"FASEB J."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s00417-003-0781-y","article-title":"Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats","volume":"241","author":"Naveh","year":"2003","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.2337\/db13-0800","article-title":"An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes","volume":"62","author":"Noonan","year":"2013","journal-title":"Diabetes"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1007\/s11064-013-1058-4","article-title":"Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats","volume":"38","author":"Ola","year":"2013","journal-title":"Neurochem. Res."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.sjbs.2016.11.017","article-title":"Neuroprotective effects of quercetin in diabetic rat retina","volume":"24","author":"Ola","year":"2017","journal-title":"Saudi J. Biol. Sci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jdiacomp.2011.11.004","article-title":"Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy","volume":"26","author":"Ola","year":"2012","journal-title":"J. Diabetes Complic."},{"key":"B168","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/jop.2015.0154","article-title":"Mesozeaxanthin protects retina from oxidative stress in a rat model","volume":"32","author":"Orhan","year":"2016","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"B169","doi-asserted-by":"publisher","first-page":"506137","DOI":"10.1155\/2011\/506137","article-title":"Regulation of posttranscriptional modification as a possible therapeutic approach for retinal neuroprotection","volume":"2011","author":"Ozawa","year":"2011","journal-title":"J. Ophthalmol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/138161212798919101","article-title":"Neuroprotective effects of lutein in the retina","volume":"18","author":"Ozawa","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1136\/bmjdrc-2015-000093","article-title":"Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system","volume":"3","author":"Pantalone","year":"2015","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"B172","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/cne.24234","article-title":"Multiple cell types form the VIP amacrine cell population","volume":"527","author":"Perez De Sevilla Muller","year":"2019","journal-title":"J. Comp. Neurol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"08002","DOI":"10.1621\/nrs.08002","article-title":"PPARalpha: energy combustion, hypolipidemia, inflammation and cancer","volume":"16","author":"Pyper","year":"2010","journal-title":"Nucleic Recept. Signal."},{"key":"B174","doi-asserted-by":"publisher","first-page":"693426","DOI":"10.1155\/2011\/693426","article-title":"Neurovascular interaction and the pathophysiology of diabetic retinopathy","volume":"2011","author":"Qian","year":"2011","journal-title":"Exp. Diabetes Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","article-title":"Fenofibrate-loaded biodegradable nanoparticles for the treatment of experimental diabetic retinopathy and neovascular age-related macular degeneration","volume":"16","author":"Qiu","year":"2019","journal-title":"Mol. Pharm."},{"key":"B176","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1167\/iovs.14-13883","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice","volume":"55","author":"Qiu","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B177","doi-asserted-by":"publisher","first-page":"31912","DOI":"10.1038\/srep31912","article-title":"AAV8-mediated angiotensin-converting enzyme 2 gene delivery prevents experimental autoimmune uveitis by regulating MAPK, NF-kappaB and STAT3 pathways","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci. Rep."},{"key":"B178","doi-asserted-by":"publisher","first-page":"e0141137","DOI":"10.1371\/journal.pone.0141137","article-title":"Losartan treatment protects retinal ganglion cells and alters scleral remodeling in experimental glaucoma","volume":"10","author":"Quigley","year":"2015","journal-title":"PLoS ONE"},{"key":"B179","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.10.004","article-title":"Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides","volume":"155","author":"Reglodi","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.14336\/AD.2018.0711","article-title":"Remote ischemic conditioning protects diabetic retinopathy in streptozotocin-induced diabetic rats via anti-inflammation and antioxidation","volume":"9","author":"Ren","year":"2018","journal-title":"Aging Dis."},{"key":"B181","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainres.2012.08.014","article-title":"Effects of bevacizumab on neuronal viability of retinal ganglion cells in rats","volume":"10","author":"Romano","year":"2012","journal-title":"Brain Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/IJN.S184574","article-title":"Neuroprotective effect of insulin-loaded chitosan nanoparticles\/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats","volume":"14","author":"Rong","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"B183","doi-asserted-by":"publisher","first-page":"E771","DOI":"10.3390\/nu11040771","article-title":"Nutraceuticals for the treatment of diabetic retinopathy","volume":"11","author":"Rossino","year":"2019","journal-title":"Nutrients"},{"key":"B184","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejphar.2004.05.019","article-title":"Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats","volume":"495","author":"Rota","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors","volume":"3","author":"Saint-Geniez","year":"2008","journal-title":"PLoS ONE"},{"key":"B186","doi-asserted-by":"publisher","first-page":"E339","DOI":"10.3390\/jcm8030339","article-title":"New insights into the mechanisms of action of topical administration of GLP-1 in an experimental model of diabetic retinopathy","volume":"8","author":"Sampedro","year":"2019","journal-title":"J. Clin. Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00125-009-1655-6","article-title":"Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes","volume":"53","author":"Sasaki","year":"2010","journal-title":"Diabetologia"},{"key":"B188","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jnutbio.2011.01.006","article-title":"Biological role of lutein in the light-induced retinal degeneration","volume":"23","author":"Sasaki","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2337\/db08-0254","article-title":"(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation","volume":"58","author":"Satofuka","year":"2009","journal-title":"Diabetes"},{"key":"B190","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12031-014-0244-4","article-title":"Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death","volume":"54","author":"Scuderi","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"B191","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cddis.2014.296","article-title":"Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma","volume":"17","author":"Semba","year":"2014","journal-title":"Cell Death Dis."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/mt.2014.179","article-title":"Oral delivery of ACE2\/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis","volume":"22","author":"Shil","year":"2014","journal-title":"Mol. Ther."},{"key":"B193","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10384-015-0415-z","article-title":"Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury","volume":"60","author":"Shimouchi","year":"2016","journal-title":"Jpn. J. Ophthalmol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12565-016-0351-0","article-title":"Pleiotropic and retinoprotective functions of PACAP","volume":"91","author":"Shioda","year":"2016","journal-title":"Anat Sci. Int."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.2337\/db09-0166","article-title":"Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes","volume":"58","author":"Silva","year":"2009","journal-title":"Diabetes"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1167\/iovs.12-10647","article-title":"Green tea is neuroprotective in diabetic retinopathy","volume":"54","author":"Silva","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B197","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2337\/dc06-1345","article-title":"Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema","volume":"30","author":"Simo","year":"2007","journal-title":"Diabetes Care"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.2337\/dc09-0565","article-title":"Advances in the medical treatment of diabetic retinopathy","volume":"32","author":"Simo","year":"2009","journal-title":"Diabetes Care"},{"key":"B199","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","article-title":"Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence","volume":"48","author":"Simo","year":"2015","journal-title":"Prog. Retin Eye Res."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1007\/s00125-018-4692-1","article-title":"Neurodegeneration in diabetic retinopathy: does it really matter?","volume":"61","author":"Simo","year":"2018","journal-title":"Diabetologia"},{"key":"B201","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc13-2002","article-title":"Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Simo","year":"2014","journal-title":"Diabetes Care"},{"key":"B202","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2019.04.010","article-title":"GLP-1: molecular mechanisms and outcomes of a complex signaling system","volume":"128","author":"Smith","year":"2019","journal-title":"Neurochem. Int."},{"key":"B203","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/nu8030140","article-title":"Extract of polygonum cuspidatum attenuates diabetic retinopathy by inhibiting the high-mobility group box-1 (HMGB1) signaling pathway in streptozotocin-induced diabetic rats","volume":"8","author":"Sohn","year":"2016","journal-title":"Nutrients"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/02713683.2017.1302591","article-title":"Calcium dobesilate prevents neurodegeneration and vascular leakage in experimental diabetes","volume":"42","author":"Sola-Adell","year":"2017","journal-title":"Curr. Eye Res."},{"key":"B205","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: a position statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2016.11.001","article-title":"Effects of blueberry anthocyanins on retinal oxidative stress and inflammation in diabetes through Nrf2\/HO-1 signaling","volume":"301","author":"Song","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S1734-1140(12)70948-9","article-title":"Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor kappaB - apoptosis pathway","volume":"64","author":"Soufi","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20120588","article-title":"Advances in our understanding of diabetic retinopathy","volume":"125","author":"Stitt","year":"2013","journal-title":"Clin. Sci."},{"key":"B209","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12640-015-9593-1","article-title":"Pituitary adenylate cyclase activating polypeptide, a potential therapeutic agent for diabetic retinopathy in rats: focus on the vertical information processing pathway","volume":"29","author":"Szabadfi","year":"2016","journal-title":"Neurotox Res."},{"key":"B210","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.neuint.2013.11.005","article-title":"PACAP promotes neuron survival in early experimental diabetic retinopathy","volume":"64","author":"Szabadfi","year":"2014","journal-title":"Neurochem. Int."},{"key":"B211","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0014-2999(01)01196-7","article-title":"Antioxidant properties of calcium dobesilate in ischemic\/reperfused diabetic rat retina","volume":"428","author":"Szabo","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"343560","DOI":"10.1155\/2013\/343560","article-title":"Pathophysiology of diabetic retinopathy","volume":"2013","author":"Tarr","year":"2013","journal-title":"ISRN Ophthalmol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0306-3623(98)00040-8","article-title":"Calcium dobesilate: pharmacology and future approaches","volume":"31","author":"Tejerina","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4103\/1947-2714.147978","article-title":"Dual blockade of Renin Angiotensin system in reducing the early changes of diabetic retinopathy and nephropathy in a diabetic rat model","volume":"6","author":"Thangaraju","year":"2014","journal-title":"N. Am. J. Med. Sci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1073\/pnas.1718592114","article-title":"Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy","volume":"114","author":"Thounaojam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B216","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1749-6632.1996.tb17509.x","article-title":"Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid","volume":"805","author":"Tuncel","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B217","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12886-017-0524-1","article-title":"Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model","volume":"17","author":"Tuzcu","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ajo.2004.04.006","article-title":"Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases","volume":"138","author":"Umeda","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12031-016-0818-4","article-title":"The protective role of PAC1-receptor agonist maxadilan in BCCAO-induced retinal degeneration","volume":"60","author":"Vaczy","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"B220","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s12031-013-9998-3","article-title":"Protective effect of alpha-melanocyte-stimulating hormone (alpha-MSH) on the recovery of ischemia\/reperfusion (I\/R)-induced retinal damage in a rat model","volume":"50","author":"Varga","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"B221","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery","volume":"61","author":"Vaudry","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"B222","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy","volume":"20","author":"Verma","year":"2012","journal-title":"Mol. Ther."},{"key":"B223","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000478784","article-title":"Calcium dobesilate is protective against inflammation and oxidative\/nitrosative stress in the retina of a type 1 diabetic rat model","volume":"58","author":"Voabil","year":"2017","journal-title":"Ophthalmic Res."},{"key":"B224","doi-asserted-by":"publisher","first-page":"970156","DOI":"10.1155\/2015\/970156","article-title":"Octreotide protects the mouse retina against ischemic reperfusion injury through regulation of antioxidation and activation of NF-kappaB","volume":"2015","author":"Wang","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"B225","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/1440-1681.12769","article-title":"Anti-inflammatory and retinal protective effects of capsaicin on ischaemia-induced injuries through the release of endogenous somatostatin","volume":"44","author":"Wang","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"e23194","DOI":"10.1371\/journal.pone.0023194","article-title":"Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS ONE"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mnfr.201200718","article-title":"Curcumin, a potential therapeutic candidate for retinal diseases","volume":"57","author":"Wang","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"B228","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1167\/iovs.18-24155","article-title":"Fenofibrate exerts protective effects in diabetic retinopathy via inhibition of the ANGPTL3 pathway","volume":"59","author":"Wang","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1159\/000330085","article-title":"Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy","volume":"27","author":"Wang","year":"2011","journal-title":"Cell Physiol. Biochem."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00125-010-1727-7","article-title":"Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina","volume":"53","author":"Wang","year":"2010","journal-title":"Diabetologia"},{"key":"B231","first-page":"594","article-title":"Catechin weakens diabetic retinopathy by inhibiting the expression of NF-kappaB signaling pathway-mediated inflammatory factors","volume":"48","author":"Wang","year":"2018","journal-title":"Ann. Clin. Lab Sci."},{"key":"B232","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ejphar.2010.10.107","article-title":"Hypothalamic proopiomelanocortin processing and the regulation of energy balance","volume":"660","author":"Wardlaw","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"E675","DOI":"10.3390\/ijms18030675","article-title":"Passage through the ocular barriers and beneficial effects in retinal ischemia of topical application of PACAP1-38 in rodents","volume":"18","author":"Werling","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B234","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1167\/iovs.16-20630","article-title":"Ocular delivery of PACAP1-27 protects the retina from ischemic damage in rodents","volume":"57","author":"Werling","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B235","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.peptides.2012.04.008","article-title":"The retinal renin-angiotensin system: roles of angiotensin II and aldosterone","volume":"36","author":"Wilkinson-Berka","year":"2012","journal-title":"Peptides"},{"key":"B236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18240\/ijo.2019.01.01","article-title":"5-aza-2\u2032-deoxycytidine in the regulation of antioxidant enzymes in retinal endothelial cells and rat diabetic retina","volume":"12","author":"Xie","year":"2019","journal-title":"Int. J. Ophthalmol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000486574","article-title":"Curcumin alleviates diabetic retinopathy in experimental diabetic rats","volume":"60","author":"Yang","year":"2018","journal-title":"Ophthalmic Res."},{"key":"B238","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1167\/iovs.09-3678","article-title":"Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma","volume":"50","author":"Yang","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B239","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejphar.2010.12.020","article-title":"Structure, function and regulation of the melanocortin receptors","volume":"660","author":"Yang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"019","DOI":"10.1007\/s12031-019-01309-9","article-title":"PACAP attenuates optic nerve crush-induced retinal ganglion cell apoptosis via activation of the CREB-Bcl-2 pathway","volume":"16","author":"Ye","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"B241","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.exer.2016.05.002","article-title":"The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression","volume":"151","author":"Zeng","year":"2016","journal-title":"Exp. Eye Res."},{"key":"B242","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1167\/iovs.07-0721","article-title":"Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes","volume":"49","author":"Zhang","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B243","doi-asserted-by":"publisher","first-page":"e93433","DOI":"10.1371\/journal.pone.0093433","article-title":"\u03b1-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1755-3768.2010.02044.x","article-title":"Neuroprotective effect of intravitreal cell-based glucagon-like peptide-1 production in the optic nerve crush model","volume":"89","author":"Zhang","year":"2011","journal-title":"Acta Ophthalmol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11427-014-4792-1","article-title":"Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis","volume":"58","author":"Zhang","year":"2015","journal-title":"Sci. China Life Sci."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.biocel.2013.03.002","article-title":"Diabetic retinopathy: neuron protection as a therapeutic target","volume":"45","author":"Zhang","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00417-008-1004-3","article-title":"Protection of exendin-4 analogue in early experimental diabetic retinopathy","volume":"247","author":"Zhang","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B248","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1167\/iovs.09-4727","article-title":"Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats","volume":"52","author":"Zhang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B249","doi-asserted-by":"publisher","first-page":"212532","DOI":"10.7573\/dic.212532","article-title":"The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy","volume":"7","author":"Zhao","year":"2018","journal-title":"Drugs Context"},{"key":"B250","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3980\/j.issn.2222-3959.2013.04.02","article-title":"Protective effects of curcumin on retinal Muller cell in early diabetic rats","volume":"6","author":"Zuo","year":"2013","journal-title":"Int. J. Ophthalmol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.regpep.2004.05.021","article-title":"Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP","volume":"123","author":"Zusev","year":"2004","journal-title":"Regul. Pept."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01172\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T12:35:05Z","timestamp":1695386105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2019.01172\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":251,"alternative-id":["10.3389\/fnins.2019.01172"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2019.01172","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"article-number":"1172"}}